Naomi Ghildiyal, MD
Sleep Medicine · Shreveport, LANPI 1316436553
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.0% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,852, more than ten times the $89 reported in 2021. That places this record below the midpoint for sleep medicine clinicians in LA, where the typical reported total is $2,943.
Across 144 payments — averaging $20.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$510
- Neurocrine Biosciences, Inc.$353
- Jazz Pharmaceuticals Inc.$337
- Inspire Medical Systems, Inc.$261
- Novartis$201
- Argenx US, Inc.$199
- plus $1K from 17 others
What the payments were for
- Food & beverage$2,70892%
- Education$2358%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 27 | $510 |
| Neurocrine Biosciences, Inc. | 37 | $353 |
| Jazz Pharmaceuticals Inc. | 11 | $337 |
| Inspire Medical Systems, Inc. | 4 | $261 |
| Novartis | 11 | $201 |
| Argenx US, Inc. | 9 | $199 |
| UCB, Inc. | 7 | $159 |
| AstraZeneca | 8 | $133 |
| Neurelis, Inc. | 3 | $124 |
| EMD Serono, Inc. | 4 | $87 |
| Davol Inc. | 1 | $84 |
| Lilly USA, LLC | 3 | $81 |
| Biogen | 4 | $77 |
| Itamar Medical Inc | 2 | $66 |
| Sanofi | 3 | $60 |
| Lundbeck LLC | 3 | $52 |
| Amgen | 1 | $28 |
| Averitas Pharma Inc. | 1 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Merz Pharmaceuticals, LLC | 1 | $22 |
| Tanabe Pharma America, Inc. | 1 | $17 |
| ANI Pharmaceuticals, Inc. | 1 | $17 |
How this compares
$2,943 in reported general payments places this provider in the 50th percentile of 20 sleep medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other sleep medicine in Shreveport
- Sara MunjampalliShreveport$19K
- Oleg ChernyshevShreveport$15K
- Brittany MonceauxShreveport$4K
- Syeda MunirShreveport$344
- Megan SmalleyShreveport$265
- Mary Beth McGannShreveport$234
- Catherine OwensShreveport$130
- Matthew AbrahamLafayette$23K
- Joseph BordelonOpelousas$8K
- Dwayne HenryBaton Rouge$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.